½ÃÀ庸°í¼­
»óǰÄÚµå
1585452

¼¼±Õ °Ë»ç ½ÃÀå : ±¸¼º¿ä¼Ò, ±â¼ú, ¼¼±Õ, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Bacteriological Testing Market by Component (Instruments, Reagents & Consumables, Test Kits), Technology (Rapid Technology, Traditional Technology), Bacteria, End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 198 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¼¼±Õ °Ë»ç ½ÃÀåÀº 2023³â 113¾ï 3,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 125¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, CAGR 10.78%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 232¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼±Õ °Ë»ç´Â °Ç°­ °ü¸®, ½ÄÀ½·á ¹× ¼öÁú Æò°¡ ºÐ¾ß¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ¹ÚÅ׸®¾ÆÀÇ °ËÃâ, ½Äº° ¹× Á¤·®È­¿¡ ÁßÁ¡À» µÎ¾î ¾ÈÀü ¹× À§»ý Ç¥ÁØÀ» ÁؼöÇϵµ·Ï º¸ÀåÇÕ´Ï´Ù. ¼¼±Õ °Ë»çÀÇ Çʿ伺Àº ½É°¢ÇÑ °Ç°­ À§±â·Î À̾îÁú ¼ö ÀÖ´Â À¯ÇØ ¼¼±ÕÀÇ È®»êÀ» ¹æÁöÇϰí, ¼ÒºñÀÚÀÇ °Ç°­À» º¸È£Çϸç, ´Ù¾çÇÑ »ê¾÷ÀÇ ±ÔÁ¦ Áؼö¸¦ º¸ÀåÇÏ´Â ´É·Â¿¡ ÀÇÇØ °­Á¶µÇ°í ÀÖ½À´Ï´Ù. ÃÖÁ¾ ¿ëµµ´Â °¨¿°¼º ÁúȯÀ» Áø´ÜÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â ÀÓ»ó ÇöÀåºÎÅÍ ½ÄÁßµ¶À» ¿¹¹æÇϱâ À§ÇÑ ½Äǰ Á¦Á¶ ¹× °¡°ø, ¾ÈÀüÇÑ ½Ä¼ö¸¦ º¸ÀåÇϱâ À§ÇÑ ¼öó¸® °øÀå±îÁö ´Ù¾çÇÕ´Ï´Ù. ½ÃÀåÀº ÇöÀç ½Äǰ ¾ÈÀü ±ÔÁ¦ °­È­, °Ë»ç ¹æ¹ýÀÇ ±â¼úÀû Áøº¸, ¼ÒºñÀÚµé »çÀÌ¿¡¼­ ³ô¾ÆÁö´Â Á¦Ç° ¾ÈÀü¿¡ ´ëÇÑ ÀÎ½Ä µîÀÇ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ´Â ½Å¼Ó °Ë»ç ŰƮ¿Í ÀÚµ¿ °Ë»ç ½Ã½ºÅÛ °³¹ß µî °Ë»çÀÇ È¿À²¼º°ú Á¤È®¼º¿¡ Çõ¸íÀ» °¡Á®¿Ã ¼ö ÀÖ´Â Å« ¼ºÀå ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ÇÏÁö¸¸ ÷´Ü °Ë»ç ±â¼ú°ú °ü·ÃµÈ ³ôÀº ºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦ »óȲ, ¼÷·ÃµÈ ±â¼úÀÚÀÇ Çʿ伺 µîÀÇ °úÁ¦´Â ¿©ÀüÈ÷ ³²¾ÆÀÖ½À´Ï´Ù. ¶ÇÇÑ, À߸øµÈ »ùÇøµ ¹× °Ë»ç Á¶°ÇÀ¸·Î ÀÎÇÑ À§¾ç¼º ¹× À§À½¼ºÀº ¿©ÀüÈ÷ ½É°¢ÇÑ ¹®Á¦À̸ç, AI¿Í ¸Ó½Å·¯´×À» ÅëÇÕÇÏ¿© ´õ ³ªÀº ¿¹Ãø ºÐ¼® ¹× °á°ú ÇØ¼®À» °¡´ÉÇÏ°Ô ÇÏ´Â ºü¸£°í ºñ¿ë È¿À²ÀûÀÌ¸ç »ç¿ëÀÚ Ä£È­ÀûÀÎ ±â¼úÀ» °³¹ßÇϱâ À§ÇØ ¿¬±¸ °³¹ßÀ» ÁøÇàÇÏ´Â °ÍÀÌ ÃÖ¼±ÀÔ´Ï´Ù. ÈÞ´ë¿ë °Ë»ç ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿¬±¸¸¦ È®´ëÇÏ¸é ¿ø°ÝÁö ¹× ÀÚ¿øÀÌ Á¦ÇÑµÈ È¯°æ¿¡ Å« ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀº ¼ºÀåÇÒ Áغñ°¡ µÇ¾î ÀÖÁö¸¸, Çõ½Å°ú Á¢±Ù¼º »çÀÌ¿¡¼­ ±ÕÇü ÀâÈù Á¢±Ù ¹æ½ÄÀ» ÅëÇØ ¾öû³­ ºñ¿ëÀ» µéÀÌÁö ¾Ê°íµµ ¾÷°è Ç¥ÁØ¿¡ ºÎÇÕÇÏ´Â ¼Ö·ç¼ÇÀ» °³¹ßÇØ¾ß ÇÕ´Ï´Ù. ±â¾÷µéÀº ±ÔÁ¦ ±â°ü ¹× ÀÇ·á ±â°ü°úÀÇ ÆÄÆ®³Ê½ÊÀ» Áß½ÃÇϰí, ÁøÈ­ÇÏ´Â ÄÄÇöóÀ̾𽺠¿ä°Ç°ú ¼¼°è ¾ÈÀü Ç¥ÁØÀÇ ¹ßÀü¿¡ ¸ÂÃß¾î ½ÃÀå Àü·«À» Á¶Á¤ÇØ¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 113¾ï 3,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 125¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 232¾ï 1,000¸¸ ´Þ·¯
CAGR(%) 10.78%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ¼¼±Õ °Ë»ç ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¹ÚÅ׸®¾Æ °Ë»ç ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ¸·Î ÀÎÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • º´¿ø¼º °¨¿° ¿¹¹æ¿¡ ´ëÇÑ °ü½É Áõ´ë
    • ½ÄÁßµ¶ Áõ°¡
    • ¾ö°ÝÇÑ ½Äǰ ¾ÈÀü ±ÔÁ¦ ½ÃÇà
    • ¹è¾ç ±â¹Ý °Ë»ç¿¡¼­ ½Å¼Ó °Ë»ç·ÎÀÇ Àüȯ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • °Ë»ç Àåºñ¿Í °ü·ÃµÈ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • ¹ÚÅ׸®¾Æ °Ë»çÀÇ ¹ßÀü
    • ¹ÚÅ׸®¾Æ ÅýÃ, ¾à¹° °Ë»ç, »ý¹°¸· Çü¼º ¿¬±¸¿ë ¹Ì¼¼ À¯Ã¼ ÀåÄ¡ÀÇ µîÀå
  • ½ÃÀå °úÁ¦
    • ½ÅÈï±¹¿¡¼­ÀÇ Á¦ÇÑµÈ ÀÎÇÁ¶ó ¹× ±â¼ú Áö¿ø

Portre's Five Forces: ¼¼±Õ °Ë»ç ½ÃÀå Ž»öÀ» À§ÇÑ Àü·« µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¼¼±Õ °Ë»ç ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¼¼±Õ °Ë»ç ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ¼¼±Õ °Ë»ç ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

¼¼±Õ °Ë»ç ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ¹ÚÅ׸®¾Æ °Ë»ç ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¼¼±Õ °Ë»ç ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ ¼¼±Õ °Ë»ç ½ÃÀå¿¡¼­ ¼º°øÀÇ ±æÀ» ±×¸®´Ù.

¼¼±Õ °Ë»ç ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ¼¼±Õ °Ë»ç ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

  • ±â±â
  • ½Ã¾à ¹× ¼Ò¸ðǰ
  • °Ë»ç ŰƮ

Á¦7Àå ¼¼±Õ °Ë»ç ½ÃÀå : ±â¼úº°

  • ½Å¼Ó ±â¼ú
  • ÀüÅë ±â¼ú

Á¦8Àå ¼¼±Õ °Ë»ç ½ÃÀå ¼¼±Õº°

  • įÇʷιÚÅÍ
  • ´ëÀå±Õ
  • ·¹Áö¿À³Ú¶ó
  • ¸®½ºÅ׸®¾Æ
  • »ì¸ð³×¶ó±Õ

Á¦9Àå ¼¼±Õ °Ë»ç ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • È­Àåǰ
  • ½Äǰ ¹× À½·á
  • ÀǾàǰ
  • ¼ö

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ¼¼±Õ °Ë»ç ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¼¼±Õ °Ë»ç ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¼¼±Õ °Ë»ç ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • 3M Company
  • Accepta Ltd.
  • Agilent Technologies, Inc.
  • ALS Limited
  • Aquagenx LLC
  • Avantor Performance Materials LLC
  • Bio-Rad Laboratories Inc.
  • bioMerieux S.A.
  • Biotrack B.V.
  • Bureau Veritas S.A.
  • Danaher Corporation
  • Eiken Chemical Co., Ltd.
  • Eurofins Scientific, Inc.
  • HiMedia Laboratories Pvt. Ltd.
  • Intertek Group PLC
  • Merck KGaA
  • Neogen Corporation
  • Romer Labs Inc.
  • SGS S.A.
  • Thermo Fisher Scientific, Inc
LSH 24.11.13

The Bacteriological Testing Market was valued at USD 11.33 billion in 2023, expected to reach USD 12.54 billion in 2024, and is projected to grow at a CAGR of 10.78%, to USD 23.21 billion by 2030.

Bacteriological testing plays a critical role within the healthcare, food & beverage, and water quality assessment sectors, focusing on detecting, identifying, and quantifying bacteria to ensure safety and compliance with health standards. The necessity of bacteriological testing is underscored by its ability to prevent the spread of harmful bacteria that could lead to significant health crises, protect consumer well-being, and ensure regulatory compliance across various industries. End-use applications span from clinical settings where it aids in diagnosing infections, to food production and processing for preventing foodborne illnesses, and in water treatment plants for ensuring safe drinking water. The market is currently influenced by increasing food safety regulations, technological advancements in testing methods, and the ever-growing awareness of product safety among consumers. These create substantial growth opportunities such as the development of rapid testing kits and automated testing systems, which could revolutionize testing efficiency and accuracy. Nevertheless, challenges persist, including high costs associated with advanced testing technologies, stringent regulatory landscapes, and the need for skilled technicians. Additionally, false positives or negatives due to poor sampling or testing conditions remain a critical concern. Innovation and research are best directed towards developing rapid, cost-effective, and user-friendly bacteriological testing technologies that integrate AI and machine learning for better predictive analytics and enhanced results interpretation. Expanding research into portable testing solutions can make a significant impact in remote or resource-limited settings. The market is poised for growth but demands a balanced approach between innovation and accessibility, ensuring solutions meet industry standards without incurring prohibitive costs. Businesses should focus on partnerships with regulatory bodies and healthcare organizations to align market strategies with evolving compliance requirements and advancing global safety standards.

KEY MARKET STATISTICS
Base Year [2023] USD 11.33 billion
Estimated Year [2024] USD 12.54 billion
Forecast Year [2030] USD 23.21 billion
CAGR (%) 10.78%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bacteriological Testing Market

The Bacteriological Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing concern regarding prevention of pathogenic infection
    • Increase in foodborne disease epidemic
    • Implementation of stringent food safety regulation
    • Inclination from culture-based tests to rapid tests
  • Market Restraints
    • High cost associated with testing equipment
  • Market Opportunities
    • Advancements in bacteriological testing
    • Emergence of microfluidic devices for studying bacterial taxis, drug testing and biofilm formation
  • Market Challenges
    • Limited infrastructure and technology support in developing countries

Porter's Five Forces: A Strategic Tool for Navigating the Bacteriological Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bacteriological Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bacteriological Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bacteriological Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bacteriological Testing Market

A detailed market share analysis in the Bacteriological Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bacteriological Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bacteriological Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bacteriological Testing Market

A strategic analysis of the Bacteriological Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bacteriological Testing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Accepta Ltd., Agilent Technologies, Inc., ALS Limited, Aquagenx LLC, Avantor Performance Materials LLC, Bio-Rad Laboratories Inc., bioMerieux S.A., Biotrack B.V., Bureau Veritas S.A., Danaher Corporation, Eiken Chemical Co., Ltd., Eurofins Scientific, Inc., HiMedia Laboratories Pvt. Ltd., Intertek Group PLC, Merck KGaA, Neogen Corporation, Romer Labs Inc., SGS S.A., and Thermo Fisher Scientific, Inc.

Market Segmentation & Coverage

This research report categorizes the Bacteriological Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across Instruments, Reagents & Consumables, and Test Kits.
  • Based on Technology, market is studied across Rapid Technology and Traditional Technology.
  • Based on Bacteria, market is studied across Campylobacter, Coliform, Legionella, Listeria, and Salmonella.
  • Based on End User, market is studied across Cosmetics, Food & Beverage, Pharmaceuticals, and Water.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing concern regarding prevention of pathogenic infection
      • 5.1.1.2. Increase in foodborne disease epidemic
      • 5.1.1.3. Implementation of stringent food safety regulation
      • 5.1.1.4. Inclination from culture-based tests to rapid tests
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with testing equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in bacteriological testing
      • 5.1.3.2. Emergence of microfluidic devices for studying bacterial taxis, drug testing and biofilm formation
    • 5.1.4. Challenges
      • 5.1.4.1. Limited infrastructure and technology support in developing countries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bacteriological Testing Market, by Component

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Consumables
  • 6.4. Test Kits

7. Bacteriological Testing Market, by Technology

  • 7.1. Introduction
  • 7.2. Rapid Technology
  • 7.3. Traditional Technology

8. Bacteriological Testing Market, by Bacteria

  • 8.1. Introduction
  • 8.2. Campylobacter
  • 8.3. Coliform
  • 8.4. Legionella
  • 8.5. Listeria
  • 8.6. Salmonella

9. Bacteriological Testing Market, by End User

  • 9.1. Introduction
  • 9.2. Cosmetics
  • 9.3. Food & Beverage
  • 9.4. Pharmaceuticals
  • 9.5. Water

10. Americas Bacteriological Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Bacteriological Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Bacteriological Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Accepta Ltd.
  • 3. Agilent Technologies, Inc.
  • 4. ALS Limited
  • 5. Aquagenx LLC
  • 6. Avantor Performance Materials LLC
  • 7. Bio-Rad Laboratories Inc.
  • 8. bioMerieux S.A.
  • 9. Biotrack B.V.
  • 10. Bureau Veritas S.A.
  • 11. Danaher Corporation
  • 12. Eiken Chemical Co., Ltd.
  • 13. Eurofins Scientific, Inc.
  • 14. HiMedia Laboratories Pvt. Ltd.
  • 15. Intertek Group PLC
  • 16. Merck KGaA
  • 17. Neogen Corporation
  • 18. Romer Labs Inc.
  • 19. SGS S.A.
  • 20. Thermo Fisher Scientific, Inc
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦